Digital Pharma dips toe into tech adoption, but is it deep enough? Ben Hargreaves looks at the uptake of enabling technology by the pharma industry.
Sales & Marketing Sponsored Start-ups and tech giants are the future of pharma marketing We are living in a revolutionary time of scientific change and innovation in pharma marketing – and the opportunities are tremendous.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
